Los Angeles Center for Ear, Nose, Throat and Allergy Opens Pasadena Office
The Los Angeles Center for Ear, Nose, Throat, and Allergy (LA CENTA) announced today the opening of their new location in Pasadena, CA. LA CENTA currently has eight locations throughout LA, making Pasadena their ninth. Founded on the principles of accessibility and availability, LA CENTA is…
Ortho Development® Announces Launch of the BKS® Uni Partial Knee System
Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced the launch of BKS® Uni, the latest addition to its portfolio of Balanced Knee® implant systems. BKS Uni is a…
Lucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuard® Esophageal Precancer Detection
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced two longitudinal clinical registries which are collecting real-world clinical utility and clinical validity data on EsoGuard® Esophageal DNA…
Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it
This is a major milestone for Human Biome, the field of microbiome medicine and whole epidemiology. Antibiotic resistance is a growing threat to public health, and new treatments are urgently needed. The New-Generation Biotherapeutic (NGB) drug candidate has the potential to…
